Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Recent patents report novel therapeutic agents for neurological disorders

March 26, 2008

ReNeuron updates strategy for ReN-001

March 25, 2008

Peptimmune completes phase I novel peptide copolymer trial in MS

March 25, 2008

Mapreg's MAP-4343 granted orphan status in Europe for spinal cord injury

March 20, 2008

Nerve growth factor mimetic peptide effective in rat neuropathic pain model

March 19, 2008

Targacept initiates phase I trial of TC-5214 in major depressive disorder

March 19, 2008

Studies point to lacosamide efficacy in painful diabetic neuropathy

March 18, 2008

Benefits lasting 6 months seen with duloxetine in fibromyalgia patients

March 18, 2008

Novel botulinum toxin type A treatment improves aspects of plantar fasciitis

March 18, 2008

Novel analgesic agents disclosed in recent Boehringer Ingelheim and GSK patents

March 18, 2008

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...